Hereditary cerebral amyloid angiopathies (CAA) are rare disorders of early onset and severe course. We describe a 47-year-old patient with Iowa-type amyloid precursor protein (APP) mutation-related hereditary CAA that manifested with concomitant lobar hemorrhage and venous sinus thrombosis. To analyze the cerebral amyloid-β burden, an amyloid-PET was performed, demonstrating low cortical retention except for the calcarine cortex. High amyloid retention was also found in the thalamus and pallidum. The co-occurrence of CAA and venous thrombosis has not been previously reported in Iowa CAA and its mechanism is yet to be elucidated. Low cortical florbetapir-PET uptake does not rule out CAA in young patients, who may benefit from genetic testing to reach diagnosis when suspicion is strong.
CharidimouA, FaridK, TsaiHH, TsaiLK, YenRF, BaronJC (2018) Amyloid-PET burden and regional distribution in cerebral amyloid angiopathy: A systematic review and meta-analysis of biomarker performance. J Neurol Neurosurg Psychiatry89, 410–417.
9.
ClarkCM, PontecorvoMJ, BeachTG, BedellBJ, ColemanRE, DoraiswamyPM, FleisherAS, ReimanEM, SabbaghMN, SadowskyCH, SchneiderJA, AroraA, CarpenterAP, FlitterML, JoshiAD, KrautkramerMJ, LuM, MintunMA, SkovronskyDM; AV-45-A16 Study Group (2012) Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: A prospective cohort study. Lancet Neurol11, 669–678.
10.
GrabowskiTJ, ChoHS, VonsattelJP, RebeckGW, GreenbergSM (2001) Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol49, 697–705.
GreenbergSM, ShinY, GrabowskiTJ, CooperGE, RebeckGW, IglesiasS, ChaponF, Tournier-LasserveE, BaronJC (2003) Hemorrhagic stroke associated with the Iowa amyloid precursor protein mutation. Neurology60, 1020–1022.
13.
MokT, ChalisseryAJ, ByrneS, CostelloeL, GalvinL, VintersHV, FarrellMA, BrettFM, MoroneyJT (2014) Familial cerebral amyloid angiopathy due to the Iowa mutation in an Irish family. Can J Neurol Sci41, 512–517.
14.
IwanowskiP, KozubskiW, LosyJ (2015) Iowa-type hereditary cerebral amyloid angiopathy in a Polish family. J Neurol Sci356, 202–204.
15.
ZarranzJJ, Fernandez-MartinezM, RodriguezO, MateosB, IglesiasS, BaronJC (2016) Iowa APP mutation-related hereditary cerebral amyloid angiopathy (CAA): A new family from Spain. J Neurol Sci363, 55–56.
16.
SellalF, WallonD, Martinez-AlmoynaL, MarelliC, DharA, OesterléH, Rovelet-LecruxA, RousseauS, KourkoulisCE, RosandJ, DiPucchioZY, FroschM, GombertC, AudoinB, MinéM, RiantF, FrebourgT, Hannequin D CampionD, GreenbergSM, Tournier-LasserveE, NicolasG (2017)
APP mutations in cerebral amyloid angiopathy with or without cortical calcifications: Report of three families and a literature review. J Alzheimers Dis56, 37–46.
17.
KomurcuHF, OkunduS, ErcanK, AnlarO (2014) A case of cerebral amyloid angiopathy associated with cerebral venous thrombosis. Int J Res Med Sci2, 1141–1143.
18.
MendelTA, Błażejewska-HyżorekB, SzpakGM, StępieńT, LewandowskaE, TarkaS, Kurkowska-JastrzębskaI, Wierzba-BobrowiczT (2017) Intracerebral hemorrhage in the context of cerebral amyloid angiopathy and varied time of onset of cerebral venous thrombosis: A case report. Folia Neuropathol55, 242–248.
19.
GreenbergSM, GrabowskiT, GurolME, SkehanME, NandigamRNK, BeckerJA, Garcia-AllozaM, PradaC, FroschMP, RosandJ, ViswanathanA, SmithEE, JohnsonKA (2008) Detection of isolated cerebrovascular β-amyloid with Pittsburgh compound B. Ann Neurol64, 587–591.
